Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Head and Neck Neoplasms 1284Squamous Cell Carcinoma of Head and Neck 707Thyroid Neoplasms 297Carcinoma, Non-Small-Cell Lung 180Mouth Neoplasms 177Neoplasms 173Breast Neoplasms 172Lung Neoplasms 152Salivary Gland Neoplasms 143Oropharyngeal Neoplasms 132Nasopharyngeal Carcinoma 128Melanoma 117Carcinoma, Squamous Cell 116Colorectal Neoplasms 112Laryngeal Neoplasms 108Ovarian Neoplasms 102Esophageal Neoplasms 100Nasopharyngeal Neoplasms 96Prostatic Neoplasms 92Pancreatic Neoplasms 92Stomach Neoplasms 88Uterine Cervical Neoplasms 86Neoplasm Metastasis 86Thyroid Cancer, Papillary 78Carcinoma, Renal Cell 78Urinary Bladder Neoplasms 74Thyroid Nodule 68Sarcoma 65Colonic Neoplasms 63Small Cell Lung Carcinoma 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Photosensitivity Disorders × Head & Neck × Clear all
NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Cyprus University of Technology

Phase NA Completed
40 enrolled
BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡